Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.
Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM. Treanor JJ, et al. Among authors: mendelman pm. J Infect Dis. 2014 Dec 1;210(11):1763-71. doi: 10.1093/infdis/jiu337. Epub 2014 Jun 20. J Infect Dis. 2014. PMID: 24951828 Free PMC article. Clinical Trial.
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.
Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL. Ramani S, et al. Among authors: mendelman pm. Clin Vaccine Immunol. 2017 May 5;24(5):e00571-16. doi: 10.1128/CVI.00571-16. Print 2017 May. Clin Vaccine Immunol. 2017. PMID: 28249841 Free PMC article. Clinical Trial.
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.
Leroux-Roels G, Cramer JP, Mendelman PM, Sherwood J, Clemens R, Aerssens A, De Coster I, Borkowski A, Baehner F, Van Damme P. Leroux-Roels G, et al. Among authors: mendelman pm. J Infect Dis. 2018 Jan 30;217(4):597-607. doi: 10.1093/infdis/jix572. J Infect Dis. 2018. PMID: 29140444 Free PMC article. Clinical Trial.
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.
Vesikari T, Saez-Llorens X, Blazevic V, Lopez P, Lopez E, Masuda T, Mendelman PM, Liu M, Sherwood J, Baehner F, Borkowski A. Vesikari T, et al. Among authors: mendelman pm. Vaccine. 2022 Jun 9;40(26):3588-3596. doi: 10.1016/j.vaccine.2022.04.089. Epub 2022 May 17. Vaccine. 2022. PMID: 35595661 Free article. Clinical Trial.
Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.
Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW Jr, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM. Bernstein DI, et al. Among authors: mendelman pm. J Infect Dis. 2015 Mar 15;211(6):870-8. doi: 10.1093/infdis/jiu497. Epub 2014 Sep 9. J Infect Dis. 2015. PMID: 25210140 Free PMC article. Clinical Trial.
Serological Correlates of Protection against a GII.4 Norovirus.
Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM. Atmar RL, et al. Among authors: mendelman pm. Clin Vaccine Immunol. 2015 Aug;22(8):923-9. doi: 10.1128/CVI.00196-15. Epub 2015 Jun 3. Clin Vaccine Immunol. 2015. PMID: 26041041 Free PMC article. Clinical Trial.
104 results